DP Clinical has significant dermatology experience, and we have conducted numerous Phase I-III studies in various dermatological indications. We understand the challenges that these studies face — from ensuring consistency in rating qualitative dermatologic endpoints to electronic assessments and ensuring high-quality data. We have worked on studies with healthy volunteers as well as target patient populations, enabling us to anticipate the challenges encountered in these studies and keep them on track. DP Clinical will help you achieve quality results, meet timelines, and maximize efficiencies by proactively navigating operational complexities, particularly in critical care dermatology trials.

Whether your study is a small, focused trial or a large, global study; DP Clinical has the knowledge and expertise to make sure our study is a success.

DP Clinical’s dermatology experience includes Phase I-III studies in the following indications:

  • Basal Cell Carcinoma
  • Burns – Full-Thickness Burns
  • Burns – Partial-Thickness Burns
  • Burns – Thermal Burns
  • Burns – Biodegradable Matrix to Treat Burn Injuries
  • Diabetic Foot Ulcers
  • Eczema
  • Injection Site Reactions
  • Lower Leg Ulcers
  • Psoriasis
  • Steroid Anti-Inflammatory
  • Venous Leg Ulcers
  • Wound Healing (burns, ulcers, cancer, etc.)